DuPont considers sale of nutrition and biosciences unit - Bloomberg
Reporting by Debroop Roy and Manojna Maddipatla in Bengaluru; Editing by Shinjini Ganguli, Reuters
Aug 6, 2019
(Reuters) - Industrial materials maker DuPont (DD.N) is considering a sale of its nutrition and biosciences unit, Bloomberg reported on Tuesday, citing people familiar with the matter.
The unit, which supplies everything from soy-based food ingredients to tablet binders, could be worth at least $20 billion as a standalone entity, Bloomberg said.
DuPont declined to comment on the unitís divestiture.
The Wilmington, Delaware-based company said in February that its overall goal was to divest about 10% of its portfolio.
DuPont was a part of DowDupont until a split...